Simoa Technology aims to transform future Alzheimer's disease detection and treatment
Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine
Learn how biomarkers can be used to transform drug approval and patient management in neurodegenerative medicine
inCerebro enhances CDD's capabilities in managing, sharing, and analysing complex research data, from its proprietary inCerebro MIND platform (Modelling with Intelligence for Novel Drugs).
Guest editorial by Arindam Ghosh, MBBS, PhD, a physician-scientist by training with extensive experience in neurodegenerative and neuropsychiatric disorders, particularly Alzheimer’s disease and dementia
Guest editorial by Mark Holland, Ph.D. Director, Bioinformatics/Biostatistics for Chemistry and Immunoassay Research and Development, Beckman Coulter
Explore how CLINICAL24 Ambassador, Dr. Vasiliki E. Kalodimou, is leveraging flow cytometry to revolutionize treatments with stem cells and regenerative medicine
nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics
ABLATOM deploys its LIBS microscope at the Grenoble Alpes University Hospital (CHUGA) to revolutionize patient diagnostics